Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. is a China-based company principally engaged in research and development, manufacture and sale of pharmaceuticals. The Company��s products are targeted for the treatment of influenza, cardio cerebrovascular diseases, rheumatoid bone diseases and in the areas of oncology, antifungal, antipyretic and gynaecology. The Company's main products include cantharidin sodium vitamin B6 injection, cantharidin sodium injection and other Chinese patent drug products. The Company distributes its products in domestic market.